Search Results for “EC” – Page 171 – media

Cardinal buys Medtronic’s Patient Recovery business for $6.1bn

Cardinal Health has concluded the purchase of Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business from Medtronic for a total of $6.1bn.
- Source: Medicaldevices-network.com
- 487
- August 1, 2017
Company Insight Market Views patient care
Plexus TG and Codonics to integrate anaesthesia safety technology

Medication management systems provider Plexus Technology Group (TG) is set to integrate its anaesthesia information management system (AIMS) with medical imaging firm Codonics’ medication safety technology Safe Label System (SLS) for an improved anaesthesia process.
- Source: Medicaldevices-network.com
- 365
- August 1, 2017
anaesthesia Company Insight
Echemi Pharma Forum , A Face-to-Face Meeting in Pharma Asia

Pharma Asia 2017 Pharma Asia is a 3 day event being held from 22nd August to the 24th August 2017 at the Karachi Expo Center in Karachi, Pakistan. This event showcases products like providing investors with a definite outlook of the regional pharmaceutical industry and an opportunity to meet their prospective counterparts and business partners etc. in the Medical & Pharmaceutical industry. Echemi Pharma Forum: From August 22 to 24, Echemi will attend Pharma Asia exhibition, and will take other three Chinese companies to this exhibition. On one side, for visitors, this is a good chance for them to know suppliers and choose their needs directly. On the other side, for suppliers, this is an opportunity to show their products and let more people know their companies. During exhibition period, Echemi will hold “Pharma Forum & Procurement Conference”, which is a face-to-face meeting for suppliers and buyers. There will be ...
- Source: Echemi
- 521
- August 1, 2017
Echemi Exhibitions & Activities ZT League Chemical
Aspect Imaging’s neonatal MRI device gains FDA clearance

Aspect Imaging has secured 510(k) clearance for the commercialisation of its neonatal brain and head magnetic resonance imaging (MRI) device from the US Food and Drug Administration (FDA).
- Source: Medicaldevice
- 502
- July 24, 2017
Aspect Imaging Company Insight FDA MRI
NovellusDx to use Gene Editing Institute’s technology for cancer diagnostics

Israel-based NovellusDx has established a genomic cancer research partnership with Christiana Care Health System's Gene Editing Institute to speed-up the development of treatments for the disease.
- Source: Medicaldevice
- 468
- July 24, 2017
cancer Company Insight NovellusDx
US researchers say blood test can detect Alzheimer’s early

Researchers at Washington University School of Medicine in St Louis, US, have carried out a study to identify a rapid and inexpensive test for Alzheimer’s disease.
- Source: Medical devices
- 443
- July 21, 2017
Alzheimer's Researches
Dune Medical’s MarginProbe destined for more than breast cancer, receives $12 million.

Dune Medical, which markets a tool that spots residual breast cancer cells following a lumpectomy, has raised $12.3 million. The funds will drive the development of the company’s technology for other types of cancer.
- Source: fiercebiotech
- 482
- July 10, 2017
breast cancer Market Views Researches
Drugdu.com(“Ddu”) attended Myanmar PHAR-MED EXPO 2017 receiving high praise

The 5th International Medical Equipment, Hospital and Pharmaceutical Exhibition (PHAR-MED EXPO 2017) was grandly held in Myanmar's capital, Yangon from July 5 - 7, 2017. As the leading global pharmaceuticals and medical devices B2B online platform, Drugdu.com (“Ddu”) participated in the exhibition and gaining an outstanding reputation from a number of exhibitors because of its business concept and service pattern.
- Source: Ddu
- 567
- July 8, 2017
Exhibitions & Activities Myanmar PHAR-MED EXPO 2017
Beta blockers may protect against heart failure

In a study conducted at York University, scientists came to the astonishing conclusion that beta blockers could protect against heart failure. This was one of the latest discoveries in a field with endless treatments managing symptoms though previously damage sustained to the heart can’t be revered.
- Source: Ddu
- 425
- June 30, 2017
beta blocker heart mortality New Approvals
One in three RA patients rejecting meds because of cost

One in three people with rheumatoid arthritis in England are not taking their medicine as prescribed because of cost, according to The National Rheumatoid Arthritis Society (NRAS).
- Source: pharmatimes
- 528
- May 14, 2017
Market Views NRAS PPC

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.